Vac­citech makes short move to new head­quar­ters; En­ter­o­Bi­otix rais­es more than $21M in Se­ries A

Ox­ford biotech Vac­citech is mov­ing head­quar­ters — but on­ly about 20 min­utes away.

Vac­citech signed a lease for 31,000 square feet with­in the Zeus de­vel­op­ment at Har­well Sci­ence and In­no­va­tion Cam­pus. The firm plans to re­lo­cate its head­quar­ters there next spring from its cur­rent head­quar­ters in Ox­ford. The length of the lease was not dis­closed.

The com­pa­ny’s op­er­a­tions will be tak­ing about half the space in that build­ing, ac­cord­ing to a Vac­citech state­ment.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.